Any EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor that interferes with the action of sterol 14alpha-demethylase (EC 1.14.14.154).
ChEBI ID: 143828
Member | Definition | Class |
---|---|---|
ravuconazole | A member of the class of triazoles that is 1-butyl-1H-1,2,4-triazole in which the butyl group is substituted at positions 2, 2, and 3 by hydroxy, 2,4-difluorophenyl, and 4-(p-cyanophenyl)-1,3-thiazol-2-yl groups, respectively (the R,R stereoisomer). It exhibits antifungal activity by inhibition of 14alpha demethylase, an enzyme involved in sterol synthesis, resulting in lysis of the fungal cell wall and fungal cell death. (NCIO4) | ravuconazole |
Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (9.92) | 18.2507 |
2000's | 61 (50.41) | 29.6817 |
2010's | 27 (22.31) | 24.3611 |
2020's | 21 (17.36) | 2.80 |
Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
---|---|---|
Trials | 7 (5.60%) | 5.53% |
Reviews | 15 (12.00%) | 6.00% |
Case Studies | 4 (3.20%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 99 (79.20%) | 84.16% |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 1.0100 | 1 | 1 |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 10.3700 | 1 | 1 |